Ozempic pill is the only oral GLP-1 medicine approved to reduce the risk of heart attack, stroke, or death in adults with type 2 diabetes who are at high risk for these events across both primary prevention (lowering the risk of major cardiovascular events in people who are at higher risk) and secondary prevention (reducing the chance of another cardiovascular event in people who have already had one)
International shipping is also available, though it naturally takes longer
Caprio M, Infante M, Moriconi E, Armani A, Fabbri A, Mantovani G, et al
While both tirzepatide and semaglutide are highly effective obesity management medications, this new study is the first to test, in a head-to-head study, the efficacy and safety of tirzepatide compared with semaglutide in adults with obesity but without type 2 diabetes
This overlap can intensify common side effects associated with GLP-1 receptor agonists, including nausea, vomiting, diarrhoea, abdominal discomfort, and constipation